The Effect of Intranasal Oxytocin on Headache Intensity and Headache-associated Symptoms in Patients Suffering From Chronic Daily Headache.

Trial Profile

The Effect of Intranasal Oxytocin on Headache Intensity and Headache-associated Symptoms in Patients Suffering From Chronic Daily Headache.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Mar 2016

At a glance

  • Drugs Oxytocin (Primary)
  • Indications Migraine; Tension type headache
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Mar 2016 According to a Trigemina media release, data of this trial will be presented at the BIO-Europe Spring 2016 Conference.
    • 08 Sep 2011 Actual end date 1 Aug 2010 added as reported by ClinicalTrials.gov.
    • 08 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top